RRoche Read More IDEAYA, Roche test IDE892/RG6505 in MTAP PDAC2026-06-03 IDEAYA entered into a clinical collaboration with Roche to evaluate IDE892, IDEAYA’s potential best-in-class Phase 1 MTA-cooperative PRMT5…
RRoche Read More IDEAYA and Roche launch IDE892 combo study in PDAC2026-06-03 Item 8.01 Other Events. Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer On June 3, 2026, IDEAYA Biosciences, Inc.…